Synonyms: Synarel®
nafarelin is an approved drug (FDA (1990))
Compound class:
Peptide or derivative
Comment: Nafarelin is a gonadotropin releasing hormone receptor agonist. The structure shown here is from PubChem CID 25077405.
|
No information available. |
Summary of Clinical Use |
Used in the treatment of central precocious puberty and endometriosis. |
Mechanism Of Action and Pharmacodynamic Effects |
For an overview of the mechanis of action of nafarelin, please see the entry on DrugBank linked to from this ligand page. |
External links |
For extended ADME data see the following: Drugs.com |